Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...
Apple Gift Cards are one of the most common Apple-related gifts given during the holidays, so if you've received one today, here are all of the things you can and cannot use it for. After redeeming an ...
Although millions of Americans use cannabis for medical reasons, new research suggests that there is not enough evidence to support much of that medicinal use. The research, published in the Journal ...
Water reuse is a vital solution to growing water insecurity—offering a reliable, climate-resilient supply for cities and industries facing increasing stress on traditional water sources. While the ...
The F.B.I. director’s travel on government jets has contributed to growing questions inside the administration about whether he is using taxpayer-funded resources inappropriately. Alexis Wilkins at ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
Jeanne Beatrix Law serves on the OpenAI Educator Council, an uncompensated group of higher education faculty who provide feedback to OpenAI on educational use cases and occasionally tests models for ...
TL;DR: Microsoft Office Professional Plus 2019 for Windows is just $19.97 (MSRP $229) through October 19 only — one payment, no subscription fees, all the essential apps you already use every day. Why ...
Anthropic is starting to train its models on new Claude chats. If you’re using the bot and don’t want your chats used as training data, here’s how to opt out. Anthropic is prepared to repurpose ...
Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...
For the first time since ChatGPT’s debut in 2022, a large trove of its user data has been made available to researchers, who attempted to answer a straightforward — but contentious and heavily ...
As someone who writes about the AI industry relatively frequently for this site, there is one question that I find myself constantly asking and being asked in turn, in some form or another: What do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback